B. A. C. Dijkmans

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

M.J. Peters, Deborah Symmons, David McCarey et al. · Annals of the Rheumatic Diseases · 2009 · 1.3K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study

Wouter H Bos, Gertjan Wolbink, Maarten Boers et al. · Annals of the Rheumatic Diseases · 2009 · 276 citations · Full text

Life Sciences, Immunology, Internal Medicine +16

The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia

Lotte A van de Stadt, A. R. van der Horst, Margret H. M. T. De Koning et al. · Annals of the Rheumatic Diseases · 2010 · 179 citations

Life Sciences, Immunology, Internal Medicine +17

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium

C A Wijbrandts, M.G.W. Dijkgraaf, Maarten C. Kraan et al. · Annals of the Rheumatic Diseases · 2007 · 152 citations · Full text

Medicine, Clinical Sciences, Immunology +17

Progression of joint damage in early rheumatoid arthritis: Association with HLA–DRB1, rheumatoid factor, and anti–citrullinated protein antibodies in relation to different treatment strategies

Jeska K de Vries‐Bouwstra, Y P M Goekoop-Ruiterman, K. N. Verpoort et al. · Arthritis & Rheumatism · 2008 · 102 citations

Life Sciences, Immunology, Pharmacotherapy +16